The National Cancer Institute (NCI) is offering the NCI Small Grants Program for Cancer Research through its R03 Clinical Trial Optional mechanism for the years 2023-2025. This program supports small research projects that can be conducted swiftly with restricted resources, including pilot studies, secondary data analyses, and the development of research methodologies. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and foreign entities, encouraging a diverse range of applicants. Funding is available for direct costs up to $50,000 per year, with a maximum project period of two years. Key dates indicate that the program is currently open for applications, with multiple application cycles throughout the years. Adherence to specified guidelines and registrations is mandatory for successful submission. The review process will assess applications based on scientific merit, relevance to cancer research areas, potential impact, and the qualifications of the researchers involved. Notably, the program emphasizes supporting diverse investigators and includes compliance with recent NIH policies regarding data management and sharing. This grant opportunity aligns with federal initiatives to bolster cancer research through accessible funding mechanisms for small-scale projects.